Surface Oncology, Inc. EBITDA Margin 2018-2023 | SURF
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surface Oncology, Inc. (SURF) over the last 10 years. The current EBITDA margin for Surface Oncology, Inc. as of June 30, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-03-31 | $0.03B | $-0.05B | -170.97% |
| 2021-12-31 | $0.00B | $-0.07B | -2466.67% |
| 2021-09-30 | $0.09B | $0.02B | 18.68% |
| 2020-12-31 | $0.13B | $0.06B | 49.61% |
| 2020-03-31 | $0.04B | $-0.03B | -71.79% |
| 2019-12-31 | $0.01B | $-0.06B | -400.00% |
| 2019-09-30 | $0.02B | $-0.05B | -187.50% |
| 2019-06-30 | $0.03B | $-0.05B | -176.92% |
| 2019-03-31 | $0.03B | $-0.04B | -157.14% |
| 2018-12-31 | $0.06B | $-0.01B | -13.56% |
| 2018-09-30 | $0.05B | $-0.02B | -37.25% |
| 2018-06-30 | $0.05B | $-0.02B | -29.41% |
| 2018-03-31 | $0.06B | $-0.01B | -9.09% |
| 2017-12-31 | $0.01B | $-0.04B | -366.67% |
